chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body aches; Headache; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 58-years-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in left arm on 20Mar2021 at 12:30 (at the age of 58 years) as a single dose for COVID-19 immunisation. Medical history included diabetes, asthma and COVID-19 on an unknown date, mushrooms allergy and citrus fruit allergy). Concomitant medication included Networking, Serialize, Venturing Inhaler from an unknown date for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since, the vaccination, the patient had not been tested for COVID-19. On 21Mar2021, patients body temperature was measured and it was found to be 100 (unspecified units) and 103.8 (unspecified units). On 21Mar2021 at 08:00 the patient experienced general body pain, headache, chills, fever (First 12 hours after injection were typical. Woke up day 2 with low grade fever 100. As the day progressed, the body aches, headache, chills, fever became intense. Fever progressed to 103.8. Fever went up and down for 72 hours. Body aches and headache also). The patient did not received any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, body aches, headache and chills were resolving. No follow-up attempts are needed. No further information is expected.
Information has been received from the wife of a 71 year old male with cancer, high blood pressure, Type II diabetes mellitus and no allergies, who on 5/23/05 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (lot # 647681/0986N). Concomitant therapy included losartan potassium and atenolol. On 5/24/05, the patient received an injection of betamtheasone with marcaine in his right arm. He initially had a local recation with redness. On 5/28/05, five days after vaccination, he vomited and developed bilateral parathesis, with numbness, swelling and tingling. He had a systemic reaction with fever and low blood pressure. He was taken to the ER. Diphenhydramine, acetaminophen (+) oxycodone and bedrest were prescribed. The patient's wife, who is a licensed practical nurse, suggested that when the pneumococcal 23v polysaccharide vaccine was given, a nerve may have been hit. At the time of report, the patient had not recovered. No product quality complaint was involved. The patient's wife considered that local reaction with redness, vomited, bilateral parathesis, systemic reaction, fever, and low blood pressure were considered to be disabling and other important medical events (OMIC). No further information is expected.
Tested positive for COVID-19; Tested positive for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 14Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 64 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Tested positive for COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Negative; (2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: Patient had re-infection of covid after completing series (Pavloxid for COVID-19). Tested negative and then tested positive 5 days later. Patient previously received covid-19 vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Painful arm, sore to move and touch. Light redness around injection site and a small patch of light redness 3-4 inches down from injection site. Appeared to look like "Red Arm Syndrome".
Approximately 12 hours after my 2nd dose vaccination I experienced the following symptoms: I started getting a headache and as the night goes on it became worse (It was the most painful headache I have experienced)- It escalated to me being physically ill. I called my doctor the next day for consultation and was advised to take Naproxen to help with the headache - which I did. I took (2) and it did help for a few hours and it came back again - and it subsided naturally the next day.
Soreness, burning, swelling, redness, itching, aches, headache, fatigue, hoarseness, nausea, sweating, cough, tightness in chest, rash, light-headedness, BP increase, lymph node swelling.
Approx 10-15 minutes after receiving the flu shot, child broke out in hives and redness from her waist up. Child became very itchy. Child has food allergies so mom gave her Benadryl. She did not eat anything new. Father and child waited at HD until the clinic opened at 1:00. By the time the MD saw her, rash was mostly gone. Mother is going to follow up with pediatrician to see what she should do next year for the flu shot.
No adverse effects reported; Received second dose of M-M-R II and Varivax 26 days after receiving first dose of M-M-R II and Varivax; Information has been received from a pharmacist concerning to a patient (age and gender not reported). No medical history, concurrent conditions nor concomitant medications were reported. On 09-JUN-2019, the patient received the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and the first dose of varicella virus vaccine live (oka/merck)(VARIVAX) (strengths, route of administration, lot numbers and expiration dates were not reported) for prophylaxis.   On 05-JUL-2019 (reported as "26 days after") (inappropriate schedule of product administration), the patient was vaccinated the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (Lot number R030808, expiration date 24-OCT-2020) (rHA) (route of administration and strength not reported) and the second dose of varicella virus vaccine live (oka/merck)(VARIVAX) (Lot number R002056, exp. date 22-JAN-2020) (route of administration and strength not reported) for prophylaxis. Both vaccines were reconstituted with sterile diluent (manufacturer unknown) (lot number N031942, exp. date 19-JUL-2020). No adverse event was reported.
it has been 2 years since patient received first dose of Shingrix; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 2 years ago from the reporting date).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional Information: GSK Receipt Date: 10-JAN-2023 Reporter's Comments: This case was reported via interactive digital media. The reporter asked, what if it had been 2 years since patient received first dose of Shingrix. Follow-up would not possible as no contact details were available. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. Note: The primary reporter was captured as other health professional conservatively due to limited information, as per source information reported into the narrative.
mild nausea; runny nose; mild headache / headache; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (COMIRNATY), on 31May2022 at 11:00 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; varicella zoster vaccine rge (cho) (SHINGRIX), on 31May2022 at 11:00 as dose 1, single (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: comirnaty (DOSE: 3, I hadn't experienced headaches or other side effects with any of the previous Comirnaty doses. My previous dose (first booster) was on 12Oct2021.), administration date: 12Oct2021, for COVID-19 immunization; Comirnaty (DOSE: 1, I hadn't experienced headaches or other side effects with any of the previous Comirnaty doses.), for COVID-19 immunization; Comirnaty (DOSE: 2, I hadn't experienced headaches or other side effects with any of the previous Comirnaty doses.), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 01Jun2022 at 06:00, outcome "unknown", described as "mild headache / headache"; NAUSEA (non-serious) with onset 01Jun2022 at 12:00, outcome "unknown", described as "mild nausea"; RHINORRHOEA (non-serious) with onset 01Jun2022 at 12:00, outcome "unknown", described as "runny nose".  Additional information: Patient received second booster of Comirnaty and first dose Shingrix yesterday, 31May2022 at 11 AM. Patient noticed a mild headache starting overnight and had a headache in the morning, walking up at 6 AM. At the time, also noticed very mild nausea, and eventually started having a runny nose at around 12 PM today. Patient had not experienced headaches or other side effects with any of the previous Comirnaty doses  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
FEW MINUTES AFTER BOTH VACCINES -DIZZINESS, LIGHTHEADED, PERSPIRING, FLUSHED, INJECTION SITE OF TWINRIX SLIGHTLY RAISED,  BP 77/56, VERY CLOSE TO PASSING OUT,  SHE DID SLOW DEEP BREATHS, COLD PACK ON NECK, FANNED WITH COOL AIR, WITHIN 20 MINUTES FELT OK TO WALK OUT WITH DAUGHTER,  CHECKED ON PATIENT A COUPLE HOURS LATER AND FELT FINE ,  ICING INJECTION SITE, BP BACK TO NORMAL
projectile vomiting  extreme joint paint  passing out  lost feeling in fingers  confusion (cognitive dysfunction) fever shortness of breath chills  skin roughness loss of apetite
Died of brain aneurism on September 5,2021 after shot in March 2021.
This spontaneous report was received from a medical assistant, referring to an unspecified number of patients. Ages, genders, medical history or concurrent conditions were not reported. Since on an unknown date, an unspecified number of improperly stored doses of VAQTA (lot # K018181, expiration date 04-JUN-2017) were administered to an unspecified number of patients. No adverse effects have been reported. The reporter stated that there was not product quality complaints involved. This is one of several cases from the same reporter. Additional information is not expected, because the reporter refused additional contact.
Lesion on the face that continued to grow (started around 4/9 3 days after vaccine). Received steroid injections into lesion on 4/12 by dermatologist but continued to grow and became raised. Went for a second opinion to another dermatologist on 4/20 - done biopsy which came back negative for all auto immune diseases and went on the oral steroid Prednisone.  This stopped the lesion from growing. As of today, there is a mark on the face but it is lighter in color and has not grown.
Taken to ER 31MAY93 for resp problems; i.e., coughing until lost breath; saw MD 9JUN93 & given ATB & bronchodil; seen by nurse on 10JUN93; child had paroxysmal cough followed by cyanosis; inst to call MD as pt also febrile; ATB was Keflex..
First dose 3/2/21 chills and sore arm.  Second dose 3/23/21 sore arm, achy muscles and joints, headache, hives Allergist Dr. recommended Allegra
MMR given 9/27/01. 10/1 pm pt had 99 degree temp, small area of red flat rash to back (approx 3" across).10/2 - temp 102F - 102.5F, vomited x 1, rash across back now. 10/3 temp 100F, continued with malaise. 10/4 - much improved with temp at ? - rash spread now to front of face.
Slight head ache (2 days on and off), feeling tired, and red swelling near site if vaccine  (larger than 2 quarters put side by side) (getting larger has been around for 2 days)
Imm on 5/12/05 Infant deceased 5/16/05 after sleeping, father reported he had fed infant, laid down to sleep checking on infant later found not breathing by father, CPR until EMS arrived at scene. Autopsy Report received which stated patient experienced pneumonitis, viral infection, petechiae and pulmonary edema.
Administered vaccine after 33 days in the refrigerator; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment drugs were reported.
shooting up high blood pressure after Pfizer vaccine almost immediately after getting the vaccine in my right arm, less than five minutes. I felt a flush go down my left arm; shooting up high blood pressure after Pfizer vaccine almost immediately after getting the vaccine in my right arm, less than five minutes. I felt a flush go down my left arm; got extreme pain all the way down to the tips of my fingers; slight tingling in the fingertips; could not move my arm; nausea; dizziness; bone pain in arms and legs; exhaustion; My arm still hurts; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration at the age of 50-years-old, administered in Arm Right on 05Mar2021 11:00 (Lot Number: EN6205) as single dose for COVID-19 immunization. Medical history included allergies to walnuts. The patient was not pregnant. The patient's concomitant medication included High blood pressure medication. The patient previously took Niacin and experienced allergies. The patient reported, "shooting up high blood pressure after Pfizer vaccine almost immediately after getting the vaccine in my right arm, less than five minutes. I felt a flush go down my left arm, starting at the top of my shoulder down to my hand and got extreme pain all the way down to the tips of my fingers with slight tingling in the fingertips. I could not move my arm, blood pressure shot up to 200 then it was 192/121 and so on I was monitored at the hospital for a couple of hours with no change or help. I went home and monitored for 29 hours it stayed elevated in the upper hundreds, spiking lowering down a few to 174/124 and spiking back up I got the vaccine on Friday at 11:00 AM my blood pressure did not break until Saturday around 3:00 p.m. I got other side effects, nausea, dizziness, bone pain in arms and legs, exhaustion but the blood pressure scared me the most. My arm still hurts to this day 12Mar2021. I was evaluated but not given anything to bring it down." The adverse events started on 05Mar2021 11:00 AM. The events resulted in Emergency room/department or urgent care, Prolongation of existing hospitalization (vaccine received during existing hospitalization). No treatment for adverse events were received. The patient underwent lab tests and procedures which included blood pressure measurement: high, up to 200 then it was 192/121 on 05Mar2021 spiking lowering down a few to 174/124 on Mar2021. The patient recovered with lasting effects. Facility type vaccine was Hospital. No other vaccine in four weeks. Not diagnosed with COVID prior vaccination. Not COVID tested post vaccination.
Fatigue from 8pm Wednesday until  10AM on Friday. Muscle discomfort in hip areas? same time course . No fever or headache!!!
(L) leg local large induration & rash, red, swollen leg after 24 hr of PENTACEL. (-) fever, (-) swg approx. 16cm x 12cm. (R) leg local rxn 4-5 cm x 4-5 cm at PREVNAR-13 site.
received second dose early; Burning up really bad, hot flashes; arm pain; felt dizzy; headache; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose early), HOT FLUSH (Burning up really bad, hot flashes), PAIN IN EXTREMITY (arm pain), DIZZINESS (felt dizzy) and HEADACHE (headache) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose early), HOT FLUSH (Burning up really bad, hot flashes), PAIN IN EXTREMITY (arm pain), DIZZINESS (felt dizzy) and HEADACHE (headache). On 08-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose early) had resolved. At the time of the report, HOT FLUSH (Burning up really bad, hot flashes), PAIN IN EXTREMITY (arm pain), DIZZINESS (felt dizzy) and HEADACHE (headache) outcome was unknown.            Patient did not take any concomitant medications.  Patient did not take any treatment medication for the symptoms.    This case was linked to MOD-2021-038163 (Patient Link).
Exact same issue (joint pain); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Exact same issue (joint pain)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Exact same issue (joint pain)). At the time of the report, ARTHRALGIA (Exact same issue (joint pain)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not reported . Treatment information was not provided.
Arm swelled to baseball size. (Patient states) - told her to go to emergency room to have checked - side flu vaccine given on.
Information has been received from a physician concerning his 10 year old daughter with no pertinent medical history and an allergy to penicillin and hay fever who at approximately one to one and a half years of age, in approximately 1997, was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck). The physician reported that his daughter received "a booster dose" of varicella virus vaccine live (Oka/Merck) (date unspecified) and the "next day" her arm was itchy at the injection site. On that same day, later at night, it was reported that the area was indurated with a red half dollar size area. The physician reported "that is morning (20 DEC 2007) the area is twice the size of yesterday. It was reported that the patient had already been seen by her pediatrician, and there are plans for her to be seen by an allergist that day. There were no symptoms after her first dose of varicella virus vaccine live (Oka/Merck). There was no concomitant therapy. Unspecified medical attention was sought. There was no product quality complaint. There were no lab diagnostic studies performed. At the time of reporting the patient had not yet recovered. Additional information has been requested.
SHORTNESS OF BREATH,  SUFFOCATION, IRRITATION/BURNING IN LUNGS, BURNING/ITCHING IN THE MOUTH
Itching at vaccine site starting 2/21 in the evening, 8 days after the vaccination. Redness near site the next day, and rash appearing on 2/23. Both the redness and rash are below the site of the vaccine on the same arm. It?s a very mild rash and is getting better now. I have photos if you want them.
Had heartbeat irregularity; This is a spontaneous report from a Pfizer-sponsored program . An unspecified age of female patient received first dose of bnt162b2 (BNT162B2; Solution for injection) via unspecified route of administration on 25Jan2021 at single dose for covid-19 immunization. Relevant medical history and concomitant medications were not provided. It was reported that on 25Jan had her first dose of the vaccine then had heartbeat irregularity yesterday and today, also taking amlodipine regularly. The outcome of the event was "Unknown".  Information on the lot/batch number has been requested.